Tahlka News Bureau
New Delhi: Popular pain relief medicine Combiflam and cold reliever D Cold Total which is most used by common man in minor aches and pain the Central Drugs Standard Control Organization (CDSCO) that regulates the sales and distribution for drugs in India has declared these two popular medicines as substandard.
Combiflam is manufactured by Sanofi India while D Cold Total is made by Reckitt Benckiser Healthcare India.
The CDSCO conducted tests last month and, in addition to the two drugs mentioned above, found Cipla's Oflox-100 DT tablets and Theo Asthalin tablets, and Cadila's Cadilose solution to be substandard.
Oflox-100 DT is an anti-biotic while Theo Asthalin is used for respiratory problems. Cadilose is usually prescribed for constipation.
Along with these drugs, the CDSCO issued an alert for 55 other drugs, all of which failed different tests in March 2017.
Action Play by Sanofi
Sanofi has said it will take "appropriate action" once it receives official notice from the drug regulator.
A company spokesperson told "Certain batches of Combiflam manufactured in 2015 were deemed substandard because the tablets showed a delay in the disintegration time. Essentially, there are several pharmaceutical parameters that are routinely assessed, one of which is to check the breakdown of a tablet in the human body. The batch identified by the CDSCO in March 2017 was also manufactured in 2015."
Sanofi had previously recalled three batches of Combiflam last year after they were found to be substandard.
Cadila Pharmaceuticals was the other company to respond to the report, it had not "received any communication on this development, hence it is not possible for us to comment on the same.